BeStock  
Stocks › Biotechnology › GPCR

Structure Therapeutics GPCR

US equityMarket cap rank #2795Biotechnology
$27.59 −$0.08 (-0.29%)
Pre-market · Oct 6, 4:20 am ET · After hours $27.71 +0.43%
Open$28.10
Prev close$27.67
Day range$26.41 – $28.21
Volume1.87M
Market cap$1.97B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts13
Average target$105.83+283.6% vs. price
  • Buy 100%
Low $70.00Now $27.59Avg $105.83High $145.00

Recent rating changes

The last 20 actions on file set price targets from $70.00 to $126.00, averaging $98.81.

DateFirmRatingTarget
9 Sep 2026 CCORF BUY $111.00
9 Sep 2026 H.C. Wainwright BUY $70.00
8 Sep 2026 LifeSci Capital BUY $104.00
8 Sep 2026 William Blair BUY –
8 Sep 2026 Jefferies BUY $125.00
8 Sep 2026 Clear Street BUY $99.00
17 Aug 2026 J.P. Morgan BUY $100.00
10 Aug 2026 Morgan Stanley BUY $126.00
10 Aug 2026 Citi BUY $97.00
7 Aug 2026 CCORF BUY $111.00
7 Aug 2026 William Blair BUY –
7 Aug 2026 Piper Sandler BUY $93.00
7 Aug 2026 H.C. Wainwright BUY $70.00
6 Aug 2026 LifeSci Capital BUY $104.00
6 Aug 2026 Citi BUY $97.00
11 Jun 2026 H.C. Wainwright BUY $70.00
9 Jun 2026 J.P. Morgan BUY –
8 Jun 2026 William Blair BUY –
12 May 2026 H.C. Wainwright BUY $100.00
9 May 2026 LifeSci Capital BUY $104.00

Discussion

No comments yet — be the first to weigh in on GPCR.

Leave a comment

Scroll to Top